Total Payments
$3,095
2024 Payments
$776.85
Companies
29
Transactions
158
Medicare Patients
2,565
Medicare Billing
$172,483
Payment Breakdown by Category
Food & Beverage$3,095 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,095 | 158 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $414.01 | 20 | $0 (2024) |
| Lilly USA, LLC | $411.43 | 21 | $0 (2024) |
| Foundation Medicine, Inc. | $385.18 | 17 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $323.96 | 17 | $0 (2024) |
| PFIZER INC. | $291.10 | 17 | $0 (2024) |
| Amgen Inc. | $182.03 | 10 | $0 (2018) |
| Daiichi Sankyo Inc. | $100.29 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $98.98 | 8 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $97.70 | 5 | $0 (2020) |
| Cumberland Pharmaceuticals, Inc. | $83.40 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $776.85 | 33 | Novartis Pharmaceuticals Corporation ($226.96) |
| 2023 | $399.17 | 16 | Merck Sharp & Dohme LLC ($106.14) |
| 2022 | $127.20 | 6 | Foundation Medicine, Inc. ($84.33) |
| 2021 | $122.31 | 8 | Foundation Medicine, Inc. ($50.70) |
| 2020 | $135.62 | 7 | Janssen Pharmaceuticals, Inc ($44.92) |
| 2019 | $359.84 | 21 | Lilly USA, LLC ($75.42) |
| 2018 | $647.90 | 35 | Lilly USA, LLC ($155.82) |
| 2017 | $526.34 | 32 | PFIZER INC. ($132.83) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $45.25 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: DESMOID TUMORS | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $28.86 | General |
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $22.36 | General |
| 07/24/2024 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $1.41 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: DESMOID TUMORS | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Medline Industries LP | Medline Industries, Inc. (Medical Supply), Medline Industries, Inc. | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Laboratory | ||||||
| 04/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $35.69 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 587 | 1,170 | $380,330 | $37,337 |
| 2022 | 14 | 612 | 1,090 | $394,317 | $38,514 |
| 2021 | 18 | 743 | 1,427 | $520,856 | $51,245 |
| 2020 | 15 | 623 | 1,157 | $464,910 | $45,386 |
Total Patients
2,565
Total Services
4,844
Medicare Billing
$172,483
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 73 | 311 | $48,096 | $6,966 | 14.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 131 | 218 | $71,461 | $6,359 | 8.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 46 | 97 | $59,633 | $6,350 | 10.6% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2023 | 23 | 102 | $52,356 | $3,520 | 6.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 96 | 120 | $40,536 | $3,305 | 8.2% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 30 | 51 | $24,767 | $2,508 | 10.1% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 35 | 37 | $27,954 | $2,434 | 8.7% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 23 | 37 | $18,007 | $2,049 | 11.4% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 18 | 32 | $10,195 | $899.71 | 8.8% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Facility | 2023 | 12 | 38 | $2,996 | $819.28 | 27.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 35 | 49 | $4,671 | $471.52 | 10.1% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 19 | 21 | $10,059 | $458.43 | 4.6% |
| 88334 | Pathology cytologic examination of specimen during surgery, each additional site | Facility | 2023 | 12 | 15 | $4,375 | $446.12 | 10.2% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 23 | 25 | $1,613 | $394.00 | 24.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 11 | 17 | $3,611 | $357.34 | 9.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 131 | 255 | $88,485 | $7,840 | 8.9% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2022 | 94 | 99 | $71,226 | $6,819 | 9.6% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 35 | 89 | $58,829 | $6,089 | 10.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 58 | 209 | $32,604 | $4,848 | 14.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 68 | 90 | $32,940 | $2,575 | 7.8% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2022 | 18 | 64 | $35,328 | $2,295 | 6.5% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2022 | 32 | 40 | $20,680 | $2,042 | 9.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 21 | 30 | $15,180 | $1,754 | 11.6% |
| 88334 | Pathology cytologic examination of specimen during surgery, each additional site | Facility | 2022 | 23 | 32 | $9,824 | $988.25 | 10.1% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Facility | 2022 | 14 | 34 | $2,618 | $770.90 | 29.4% |
About Elham Abboud
Elham Abboud is a Specialist/Technologist, Pathology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164409447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elham Abboud has received a total of $3,095 in payments from pharmaceutical and medical device companies, with $776.85 received in 2024. These payments were reported across 158 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,095).
As a Medicare-enrolled provider, Abboud has provided services to 2,565 Medicare beneficiaries, totaling 4,844 services with total Medicare billing of $172,483. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist/Technologist, Pathology
- Other Specialties Pathology|Anatomic Pathology & Clinical Pathology|Anatomic Pathology & Clinical Pathology
- Location Chicago, IL
- Active Since 12/28/2005
- Last Updated 12/30/2025
- Taxonomy Code 246Q00000X
- Entity Type Individual
- NPI Number 1164409447
Products in Payments
- KEYTRUDA (Biological) $399.41
- FOUNDATIONONE (Device) $280.44
- VERZENIO (Drug) $163.84
- CYRAMZA (Drug) $148.50
- KISQALI (Drug) $139.84
- ELIQUIS (Drug) $121.28
- Aranesp (Biological) $102.89
- XARELTO (Drug) $97.70
- OPDIVO (Biological) $87.89
- CHANTIX (Drug) $86.23
- Lenvima (Drug) $70.83
- INJECTAFER (Drug) $70.23
- OGSIVEO (Drug) $68.67
- Neulasta (Biological) $60.06
- PADCEV (Biological) $54.97
- MEKINIST (Drug) $53.50
- ALIMTA (Drug) $50.12
- Xtandi (Drug) $47.14
- GILOTRIF (Drug) $45.90
- LUTATHERA (Drug) $45.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.